Brown Brothers Harriman & CO Baxter International Inc Transaction History

Brown Brothers Harriman & CO

$12.7 Billion
Q2 2024

A detailed history of Brown Brothers Harriman & CO transactions in Baxter International Inc stock. As of the latest transaction made, Brown Brothers Harriman & CO holds 19,232 shares of BAX stock, worth $757,163. This represents 0.01% of its overall portfolio holdings.

Number of Shares

19,232

Previous 21,664 11.23%

Holding current value

$757,163

Previous $925,000 30.49%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$32.87 - $43.55 $79,939 - $105,913	-2,432 Reduced 11.23%	19,232 $643,000
Q1 2024 May 10, 2024	SELL	$37.88 - $43.77 $258,455 - $298,642	-6,823 Reduced 23.95%	21,664 $925,000
Q4 2023 Feb 12, 2024	SELL	$31.71 - $38.95 $213,566 - $262,328	-6,735 Reduced 19.12%	28,487 $1.1 Million
Q3 2023 Nov 13, 2023	SELL	$37.32 - $49.29 $227,465 - $300,422	-6,095 Reduced 14.75%	35,222 $1.33 Million
Q2 2023 Aug 07, 2023	SELL	$39.98 - $47.68 $254,832 - $303,912	-6,374 Reduced 13.37%	41,317 $1.88 Million
Q1 2023 May 11, 2023	SELL	$37.58 - $52.57 $457,874 - $640,512	-12,184 Reduced 20.35%	47,691 $1.93 Million
Q4 2022 Feb 09, 2023	SELL	$49.7 - $57.71 $1.66 Million - $1.93 Million	-33,445 Reduced 35.84%	59,875 $3.05 Million
Q3 2022 Nov 10, 2022	SELL	$53.86 - $66.8 $1.48 Million - $1.84 Million	-27,474 Reduced 22.74%	93,320 $5.03 Million
Q2 2022 Aug 11, 2022	SELL	$63.83 - $80.0 $6.99 Million - $8.77 Million	-109,566 Reduced 47.56%	120,794 $7.76 Million
Q1 2022 May 13, 2022	SELL	$76.85 - $89.45 $214 Million - $249 Million	-2,782,247 Reduced 92.35%	230,360 $17.9 Million
Q4 2021 Feb 14, 2022	SELL	$74.57 - $87.19 $2.83 Million - $3.3 Million	-37,892 Reduced 1.24%	3,012,607 $259 Million
Q3 2021 Nov 15, 2021	SELL	$73.77 - $83.61 $7.39 Million - $8.38 Million	-100,168 Reduced 3.18%	3,050,499 $245 Million
Q2 2021 Aug 13, 2021	SELL	$80.5 - $88.01 $3.71 Million - $4.06 Million	-46,102 Reduced 1.44%	3,150,667 $254 Million
Q1 2021 May 13, 2021	SELL	$76.38 - $86.03 $27.3 Million - $30.7 Million	-356,881 Reduced 10.04%	3,196,769 $270 Million
Q4 2020 Feb 16, 2021	SELL	$75.39 - $82.36 $9.23 Million - $10.1 Million	-122,411 Reduced 3.33%	3,553,650 $285 Million
Q3 2020 Nov 16, 2020	BUY	$78.33 - $90.73 $48.1 Million - $55.7 Million	613,470 Added 20.03%	3,676,061 $296 Million
Q2 2020 Aug 13, 2020	SELL	$78.66 - $94.14 $9.27 Million - $11.1 Million	-117,900 Reduced 3.71%	3,062,591 $264 Million
Q1 2020 May 15, 2020	BUY	$71.57 - $93.3 $225 Million - $294 Million	3,150,288 Added 10430.38%	3,180,491 $258 Million
Q4 2019 Feb 14, 2020	SELL	$76.7 - $88.45 $84,370 - $97,295	-1,100 Reduced 3.51%	30,203 $2.53 Million
Q3 2019 Nov 14, 2019	SELL	$81.4 - $89.78 $412,942 - $455,453	-5,073 Reduced 13.95%	31,303 $2.74 Million
Q2 2019 Aug 14, 2019	SELL	$73.44 - $82.41 $142,400 - $159,792	-1,939 Reduced 5.06%	36,376 $2.98 Million
Q1 2019 May 15, 2019	SELL	$64.48 - $81.31 $326,978 - $412,323	-5,071 Reduced 11.69%	38,315 $3.12 Million
Q4 2018 Feb 14, 2019	BUY	$61.45 - $77.8 $293,423 - $371,495	4,775 Added 12.37%	43,386 $2.86 Million
Q2 2018 Aug 14, 2018	BUY	$63.43 - $75.41 $68,821 - $81,819	1,085 Added 2.89%	38,611 $2.85 Million
Q1 2018 May 14, 2018	SELL	$62.56 - $72.26 $34,658 - $40,032	-554 Reduced 1.45%	37,526 $2.44 Million
Q4 2017 Feb 14, 2018	BUY	$61.45 - $66.05 $21,630 - $23,249	352 Added 0.93%	38,080 $2.46 Million
Q3 2017 Nov 14, 2017	SELL	$59.5 - $64.61 $355,334 - $385,850	-5,972 Reduced 13.67%	37,728 $2.37 Million
Q2 2017 Aug 14, 2017	BUY	N/A	43,700	43,700 $2.65 Million

Others Institutions Holding BAX

# of Institutions

981

Shares Held

446M

Call Options Held

2.22M

Put Options Held

3.04M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $19.8B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

News

Stay updated on Brown Brothers Harriman & CO with notifications on news.

Account

Brown Brothers Harriman & CO Baxter International Inc Transaction History